Anticoagulaiton drugs Flashcards

1
Q

indications for antiocoagulants?

A

venous thrombosis
Afib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MofA- anticoagulants?

A

target formation of fibrin clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

naturally occuring anticoagulants?

A

-serine protease inhibitors
-Protein C and Protein S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mofa heparin?

A

-activates antithrombin

Unfractioned heparin:
-antithrombin binds to thrombin + Xa

LMWH:
-antithrombin binds to Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how long does it take for heparin to work?

A

immediate effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2 forms of heparin?

A
  1. unfractioned
  2. LMWH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mofa unfractioned heparin?

A

Activates antithrombin and predominantly inhibits thrombin (but also works on Xa )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

mofa LMWH heparin?

A

Activates antithrombin (binds to it) and inhibits Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how to monitor unfractioned heparin?

A

Activated partial thromboplastin time (APTT) for unfractionated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how to monitor LMWH?

A

Anti-Xa assay for LMWH – but usually no monitoring of LMWH required

As factor 10a is in centre of haemostasis – will affect PT and APTT, but much more sensitive to APTT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why use unfracitionated over LMWH?

A

unfractionated easier to reverse so may use if patient is more prone to bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

complications of heparin?

A

Bleeding – as more anticoagulated

Heparin induced thrombocytopenia (with thrombosis) - monitor FBC in patients on heparin (more common in unfractionated)

Osteoporosis with long term use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what to do if patient is on heparin and starts bleeding?

A

Stop heparin – has short half life (will take longer to disappear in LMWH)

If severe bleeding:
-Protamine sulphate (antidote)
-Reverses antithrombin effect, complete reversal for unfractionated and partial reversal for LMWH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

examples of coumarin anticoagulants?

A

warfarin, phenindione, acenocoumarin, phenprocoumon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

where are clotting factors made?

A

usually in liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Role of Vitamin K?

A

-Fat soluble vitamin, absorbed in jejeunum + ileum of intestine, requires bile salts for absorption

Final carboxylation of clotting factors 2 (prothrombin), 7, 9, 10 – all key components in secondary haemostasis

-also affect protein C and protein S (natural anticoagulants)– these drop initially on warfarin therapy, so always give heparin initially too

-Synthesised in liver

17
Q

MofA of warfarin?

A

inhibition of vitamin K:
-vitamin K helps make clotting factors 2 (prothrombin), 7, 9, 20
-also affect protein C and protein S (natural anticoagulants)

18
Q

what should be done in the initiation of warfarin?

A

should give heparin too
-as Warfarin also affect protein C and protein S (natural anticoagulants)– these drop initially on warfarin therapy, so always give heparin initially too

rapid- acute thrombosis
slow- in community, so not big affect on protein C or S

19
Q

how is warfarin monitored?

A

-INR
-PT and APTT prolonged (due to factor 2, 7, 9 and 10 being affected)
-clotting factor 7 has shortest has life and so PT prolonged the most

20
Q

what clotting factor has the shortest half life and what effect does that have?

A

o Shortest half-life is factor 7, so PT prolonged the most

21
Q

calculation for INR?

A
22
Q

Complications of Warfarin?

A

Haemorrhage

Bleeding complications:
Mild – skin bruising, epistaxis, haematuria
Severe – GI, intracerebral, significant drop in Hb

23
Q

risk factors for complications of a haemorrhage when on warfarin?

A

Risk factors – intensity of anticoagulation, concomitant clinical disorders, concomitant use of other medications, drug interactions, quality of management

24
Q

management of bleeding when patient is on warfarin?

A

Management depends on severity of bleeding and INR

Omit warfarin doses – hopefully bring INR down

If not, administer oral vitamin K – 6 hours to work

If severe :
-Give prothrombin complex concentrate (PTCC)
-If no PTCC available give FFP (takes longer to thaw so not first line)

25
Q

examples of new anticoagulants?

A

thrombin and Xa inhibitors

26
Q

examples of Xa inhibitors?

A

E.g. edoxaban, rivaroxaban, apixaban

27
Q

examples of thrombin inhibitors?

A

dabigatran

28
Q

MofA- dabigatran?

A

thrombin inhibitrs
-target thrombin

29
Q

CI thrombin inhibitors e.g. dabigatran?

A

caution - predominantly renally excreted so can accumulate and lead to bleeding complications if any renal co-morbidities/UTI

30
Q

advantages of thrombin inhibitors?

A

less drug interactions

31
Q

MofA edoxaban, rivaroxaban and apixaban?

A

Target factor 10a
Xa inhibitors

32
Q

advantages of edoxaban, rivaroxaban and apixaban?

A

less drug interactions

33
Q

what is heparin induced thrombocyotpenia?

A

-development of antibodies against platelets in response to heparin exposure causing platelet destruction (thrombocyopenia) and blood clots

34
Q

PATHOPHYSIOLOGY- heparin induced thrombocytopenia?

A

Development of antibodies against platelets in response to exposure to heparin

Anti-PF4/ heparin antibodies:
-Antibodies target platelet factor 4 (PF4) on platelets
- Bind to platelets and activate clotting mechanisms, causing hypercoagulable state leading to thrombosis
-Also break down platelets causing thrombocytopenia

35
Q

investigations- heparin induced thrombocytopenia?

A

HIT antibodies:
-Anti PF4
-anti heparin

Low platelets (thrombocytopenia)
Blood clots